MiMedx (NSDQ:MDXG) said it inked a distribution deal with Medtronic (NYSE:MDT) for its Purion allograft line.
Spine
NuVasive debuts Precept spinal system in Japan
California medical device company NuVasive Inc. (NSDQ:NUVA) debuted its Precept spinal implant in Japan, treating the 1st patients with the posterior fixation system.
Alphatec to lay off 76 from Scient’x, Surgiview subsidiaries
Japan clears SpineGuard’s PediGuard surgical device
SpineGuard (EPA:ALSGD) said it landed Japanese Ninsho approval for its PediGuard, a handheld surgical product that helps guide proper spine screw placement.
InVivo Therapeutics plunges again as interim CFO quits after 2 weeks
InVivo Therapeutics (OTC:NVIV) shares plunged some 22% today after the medical device company reported that its interim CFO, appointed 2 weeks ago after the sudden departure of CEO & CFO Frank Reynolds, had resigned effective immediately.
St. Jude-backed Spinal Modulation enrolls 1st patient in pain management study
FDA puts highest-risk label on Stryker’s spinal device recall
Updated August 30, 2013, at 4:00 p.m. with comments from Stryker.
The FDA issued a Class I recall for 5 lots of Stryker Spine’s Oasys Midline Occipital Plate, warning patients and physicians that the device might fracture after surgery.
California spinal startup announces $3.6M IPO
Carlsbad, Calif.-based Aurora Spine is hoping to round up as much as $3.6 million through an initial public offering, launched today, through which the company is issuing nearly 5.2 million shares at a per-share price of 70¢.
Texas spinal devices maker LDR Holding shoots for IPO of up to $69M
LDR Holding Corp. announced that it’s making a bid for its initial public offering, aiming to sell its stock on the NASDAQ global market under the stock ticker ‘LDRH’, according to a company statement.
The company Texas-based spinal device company did not disclose the number of shares or detailed pricing for the IPO, but filed for an offering of up to $69 million, SEC documents show.
InVivo tanks on push-back for spinal injury trial
Biomet units lose $2.7M royalty dispute with spine surgeon
Two Biomet subsidiaries are on the hook for some $2.7 million in royalty payments to a prominent spine surgeon it stopped paying in 2008, after a New Jersey appeals court upheld a lower court’s ruling in Dr. Neil Kahanovitz’s favor.